Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl
US6432991B1 · kind B1 · utility
6Cited by
3References
15Claims
0Family size
Inventor
Key dates
| Filing date | Jul 27, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Sep 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/426
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Effects of MAO-A or MAO-B inhibitors such as L-deprenyl on both cerebral and peripheral vasculature, on non-vascular smooth muscle, on the nervous system, and on platelets, RBC, WBC, mast cells, macrophages, and glial cells are disclosed. The effects are the result of a mode of action for MAO-A or MAO-B inhibitors such as L-deprenyl which is totally unrelated to selective inhibition of MAO-A and/or MAO-B. Therapeutic methods of using MAO-A or MAO-B inhibitors such as L-deprenyl to treat a variety of disorders are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.